Pharmacy Report Archives - Page 44 of 139 - Becker's Hospital Review

10 most responsible drugmakers | Pfizer donates cancer drug rights | The cost of 'unsupported' drug price hikes | Beth Israel Lahey restructures execs | Walmart pilots in-store mammograms

December 12, 2023 BHR Newsletter 1. 'Unsupported' drug price increases cost payers $1.3B: ICER Full story 2. Pfizer donates rights to cancer drug Full story 3. 10 drugmakers on Newsweek's list of most responsible healthcare companies Full story 4. How does…

Hospitals offer new CRISPR therapy | 8 influential drug approvals in '23 | Walgreens expands COVID, flu services | Pharmacist to pay $573K for fraud | Fla. ERs face new rules

December 11, 2023 BHR Newsletter 1. 9 hospitals cleared to deliver new CRISPR-based sickle cell treatment Full story 2. 8 most influential drug approvals in 2023: GoodRx Full story 3. Walgreens expands testing, treatment options for COVID-19, flu Full story…

From pharmacist to hospital CEO: 2 paths | US targets drug patents | Why retail pharmacists are protesting | 10 systems seeking pharmacy leaders | Millions of syringes in limbo

December 7, 2023 BHR Newsletter 1. Biden administration OKs ability to seize drug patents to lower costs Full story 2. Why non-union pharmacists are protesting Full story 3. How 2 pharmacy leaders became hospital CEOs Full story 4. How does your…

Mark Cuban, CVS and the transparency wave | Zepbound hits shelves | Cyberattack delays refills at NM system | ChatGPT falls short on drug queries | 3 patients die in cancer drug trial

December 6, 2023 BHR Newsletter 1. After cyberattack, patients struggle to fill scripts at New Mexico system Full story 2. The Mark Cuban effect on drug pricing Full story 3. Most of ChatGPT's answers to drug questions are wrong: Study Full…

CVS to alter drug pricing | Lawmakers probe FDA's decongestant decision | Top 132 hospitals: Leapfrog | Texas sues Pfizer over COVID shot | 50 states ranked by health

December 5, 2023 BHR Newsletter 1. CVS to revamp drug pricing model Full story 2. Lawmakers probe FDA's decongestant decision Full story 3. Leapfrog: Top 132 hospitals of 2023 Full story 4. How does your system manage rare disease patients?…

Hospital pharmacies in 2024: What to know | FDA posts warning for 2 antiseizure drugs | Pfizer scraps weight loss drug candidate | Ill. hospitals win medication security case | ACA regains attention

December 4, 2023 BHR Newsletter 1. ASHP: What pharmacy leaders should know heading into 2024 Full story 2. Some antiseizure drugs can cause extensive rash, FDA warns Full story 3. Hospitals can store fingerprint data for medication security, Illinois Supreme…

Avoid China-made syringes: FDA | 340B yields mixed results: 5 notes | Cigna, Humana 'in talks' to merge | Denver Health gives Ebola shots | 10 systems seeking pharmacy leaders

November 30, 2023 BHR Newsletter 1. Denver Health administers 1st shots of Ebola vaccines Full story 2. Mixed results on how hospitals use 340B funds: 5 things to know Full story 3. Avoid syringes made in China, FDA says Full story…

FDA probes CAR-T drugs for cancer risk | CVS sues US | Mark Cuban expands pharmacy network | Menopausal women turn to GLP-1s | MercyOne buys pharmacy

November 29, 2023 BHR Newsletter 1. FDA investigates potential link between CAR-T therapy and lymphoma Full story 2. Menopausal women turn to Wegovy, Ozempic for weight loss Full story 3. CVS sues US over $400M in denied tax deductions Full…

US plugs $35M into drug supply chain | Cuban's pharmacy taps new partner | Wis. probes hospital pharmacist | 1st desmoid tumor drug approved | Patient death spurs infusion pump warning

November 28, 2023 BHR Newsletter 1. Biden to use Cold War-era policy to boost drug supply chain Full story 2. FDA approves 1st drug for aggressive, noncancerous tumors Full story 3. Mark Cuban Cost Plus Drugs partners with digital health…

Mounjaro outpaces Ozempic in weight loss study | RSV drugs in high demand | 400K meds pulled in Class I recall | Calif. system sues Optum | Hubris trips Amazon's healthcare venture

November 27, 2023 BHR Newsletter 1. Mounjaro more effective than Ozempic for weight loss: Study Full story 2. FDA finalizes guidelines on real-time cancer drug review Full story 3. Uptake of RSV drugs spikes early Full story 4. Healthcare execs,…